| Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma I Comino-Méndez, FJ Gracia-Aznárez, F Schiavi, I Landa, ... Nature genetics 43 (7), 663-667, 2011 | 584 | 2011 |
| Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes LJ Leandro‐García, S Leskelä, I Landa, C Montero‐Conde, ... Cytoskeleton 67 (4), 214-223, 2010 | 311 | 2010 |
| Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre … J Garcia-Donas, E Esteban, LJ Leandro-García, DE Castellano, ... The lancet oncology 12 (12), 1143-1150, 2011 | 287 | 2011 |
| The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients S Leskelä, LJ Leandro-García, M Mendiola, J Barriuso, L Inglada-Pérez, ... Endocrine-related cancer 18 (1), 85-95, 2011 | 239 | 2011 |
| Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas E López-Jiménez, G Gómez-López, LJ Leandro-García, I Muñoz, ... Molecular endocrinology 24 (12), 2382-2391, 2010 | 225 | 2010 |
| Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis I Comino-Méndez, AA de Cubas, C Bernal, C Álvarez-Escolá, ... Human molecular genetics 22 (11), 2169-2176, 2013 | 179 | 2013 |
| Genetics of pheochromocytoma and paraganglioma in Spanish patients A Cascon, G Pita, N Burnichon, I Landa, E Lopez-Jimenez, ... The Journal of Clinical Endocrinology & Metabolism 94 (5), 1701-1705, 2009 | 165 | 2009 |
| Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity S Leskelä, C Jara, LJ Leandro-Garcia, A Martinez, J Garcia-Donas, ... The pharmacogenomics journal 11 (2), 121-129, 2011 | 163 | 2011 |
| Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis C Rodríguez-Antona, J Pallares, C Montero-Conde, L Inglada-Pérez, ... Endocrine-Related Cancer 17 (1), 7-16, 2010 | 141 | 2010 |
| Molecular characterisation of a common SDHB deletion in paraganglioma patients A Cascon, I Landa, E Lopez-Jimenez, A Díez-Hernández, M Buchta, ... Journal of medical genetics 45 (4), 233-238, 2008 | 89 | 2008 |
| Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma J Garcia-Donas, LJ Leandro-Garcia, AG Del Alba, M Morente, I Alemany, ... Annals of oncology 24 (9), 2409-2414, 2013 | 88 | 2013 |
| Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy LJ Leandro-García, L Inglada-Pérez, G Pita, E Hjerpe, S Leskelä, C Jara, ... Journal of medical genetics 50 (9), 599-605, 2013 | 81 | 2013 |
| Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy M Apellániz-Ruiz, MY Lee, L Sánchez-Barroso, G Gutiérrez-Gutiérrez, ... Clinical Cancer Research 21 (2), 322-328, 2015 | 80 | 2015 |
| Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy LJ Leandro-García, S Leskelä, C Jara, H Gréen, E Åvall-Lundqvist, ... Clinical Cancer Research 18 (16), 4441-4448, 2012 | 79 | 2012 |
| SWI/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies M Saqcena, LJ Leandro-Garcia, JLV Maag, V Tchekmedyian, ... Cancer Discovery 11 (5), 1158-1175, 2021 | 66 | 2021 |
| Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways AA De Cubas, LJ Leandro-García, F Schiavi, V Mancikova, ... Endocrine-related cancer 20 (4), 477-493, 2013 | 62 | 2013 |
| Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma A Cascon, E Lopez-Jimenez, I Landa, S Leskelä, LJ Leandro-García, ... Hormone and metabolic research 41 (09), 672-675, 2009 | 53 | 2009 |
| SDHC mutation in an elderly patient without familial antecedents E López‐Jiménez, JM De Campos, EM Kusak, I Landa, S Leskelä, ... Clinical Endocrinology 69 (6), 906-910, 2008 | 49 | 2008 |
| Deep sequencing reveals microRNAs predictive of antiangiogenic drug response J García-Donas, B Beuselinck, L Inglada-Pérez, O Graña, P Schöffski, ... JCI insight 1 (10), 2016 | 47 | 2016 |
| Allelic variant at− 79 (C> T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels I Landa, C Montero-Conde, D Malanga, S De Gisi, G Pita, ... Endocrine-Related Cancer 17 (2), 317-328, 2010 | 46 | 2010 |
